Medication Guide App

Label Changes for:

MS Contin (morphine sulfate) controlled-release tablets

May 2010

Changes have been made to the ADVERSE REACTIONS sections of the safety label.

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) – May 2010

ADVERSE REACTIONS

Less Frequently Observed Reactions
  • malaise, thinking disturbances, vertigo
Hide
(web4)